{"id":51498,"date":"2022-12-02T12:02:34","date_gmt":"2022-12-02T11:02:34","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/"},"modified":"2022-12-02T12:02:34","modified_gmt":"2022-12-02T11:02:34","slug":"global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/","title":{"rendered":"Global Transcriptomics Market Report to 2031 &#8211; Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5681821\/global-transcriptomics-market-2021-2031-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=7vcrtk&amp;utm_campaign=1783373+-+Global+Transcriptomics+Market+Report+to+2031+-+Featuring+10x+Genomics%2C+Agilent+Technologies%2C+Bio-Techne+and+Cytiva+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Transcriptomics Market 2021-2031 by Component, Technology, Application, End User, and Region: Trend Forecast and Growth Opportunity&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221202005153\/en\/1653552\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221202005153\/en\/1653552\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global transcriptomics market will reach $ 16,077.8 million by 2031, growing by 10.7% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&amp;D expenditure.\n<\/p>\n<p>\nThe report is based on a comprehensive research of the entire global transcriptomics market and all its sub-segments through extensively detailed classifications.\n<\/p>\n<p>\nProfound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.\n<\/p>\n<p>\nThe report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)\n<\/p>\n<p>\n<strong>In-depth qualitative analyses include identification and investigation of the following aspects:<\/strong>\n<\/p>\n<ul>\n<li>\nMarket Structure\n<\/li>\n<li>\nGrowth Drivers\n<\/li>\n<li>\nRestraints and Challenges\n<\/li>\n<li>\nEmerging Product Trends &amp; Market Opportunities\n<\/li>\n<li>\nPorter&#8217;s Fiver Forces\n<\/li>\n<\/ul>\n<p>\nThe trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict.\n<\/p>\n<p>\nThe balanced (most likely) projection is used to quantify global transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Region.\n<\/p>\n<p>\n<strong>Based on Component, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nInstruments\n<\/li>\n<li>\nConsumables\n<\/li>\n<li>\nSoftware\n<\/li>\n<li>\nServices\n<\/li>\n<\/ul>\n<p>\n<strong>Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nPolymerase Chain Reaction (PCR)\n<\/li>\n<li>\nNext-Generation Sequencing\n<\/li>\n<li>\nMicroarray\n<\/li>\n<li>\nIn-Situ Hybridization (ISH)\n<\/li>\n<li>\nGene Regulation Technologies\n<\/li>\n<li>\nOther Technologies\n<\/li>\n<\/ul>\n<p>\n<strong>By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nDrug Discovery and Development\n<\/li>\n<li>\nDiagnostics\n<\/li>\n<li>\nSingle Cell Analysis\n<\/li>\n<li>\nGene Expression\n<\/li>\n<li>\nCell Biology\n<\/li>\n<li>\nOther Applications\n<\/li>\n<\/ul>\n<p>\n<strong>By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nAcademic and Research Institutions\n<\/li>\n<li>\nBiotechnology and Biopharmaceutical Companies\n<\/li>\n<li>\nContract Research Organizations (CROs)\n<\/li>\n<li>\nOther End Users\n<\/li>\n<\/ul>\n<p>\n<strong>Geographically, the following regions together with the listed national\/local markets are fully investigated:<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America (U.S., Canada, and Mexico)\n<\/li>\n<li>\nEurope (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)\n<\/li>\n<li>\nAPAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)\n<\/li>\n<li>\nSouth America (Brazil, Chile, Argentina, Rest of South America)\n<\/li>\n<li>\nMEA (UAE, Saudi Arabia, South Africa and Rest of MEA)\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\n10x Genomics\n<\/li>\n<li>\nAgilent Technologies, Inc.\n<\/li>\n<li>\nANGLE plc\n<\/li>\n<li>\nBecton, Dickinson and Company (BD)\n<\/li>\n<li>\nBio-Rad Laboratories, Inc.\n<\/li>\n<li>\nBioSypder, Inc.\n<\/li>\n<li>\nBio-Techne\n<\/li>\n<li>\nCytiva\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd.\n<\/li>\n<li>\nFluidigm Corporation\n<\/li>\n<li>\nGE Healthcare\n<\/li>\n<li>\nIllumina, Inc.\n<\/li>\n<li>\nMenarini Silicon Biosystems\n<\/li>\n<li>\nMerck &amp; Co., Inc.\n<\/li>\n<li>\nNanoString\n<\/li>\n<li>\nPacific Biosciences of California, Inc.\n<\/li>\n<li>\nPerkinElmer Inc.\n<\/li>\n<li>\nPromega Corporation\n<\/li>\n<li>\nQiagen N. V.\n<\/li>\n<li>\nTakara Bio Inc.\n<\/li>\n<li>\nThermo Fisher Scientific Inc.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5681821\/global-transcriptomics-market-2021-2031-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=7vcrtk&amp;utm_campaign=1783373+-+Global+Transcriptomics+Market+Report+to+2031+-+Featuring+10x+Genomics%2C+Agilent+Technologies%2C+Bio-Techne+and+Cytiva+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/2batn7<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;&#108;&#x74;&#x6f;&#58;&#x70;&#x72;&#101;&#x73;&#x73;&#64;&#x72;&#x65;&#115;&#x65;&#x61;&#114;&#x63;&#x68;&#97;&#x6e;&#x64;&#109;&#x61;&#x72;k&#x65;&#x74;s&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;&#101;&#x73;&#115;&#x40;r&#x65;s&#x65;a&#114;&#x63;&#104;&#x61;&#110;&#x64;&#109;&#x61;r&#x6b;e&#x74;s&#46;&#x63;&#111;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Transcriptomics Market 2021-2031 by Component, Technology, Application, End User, and Region: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global transcriptomics market will reach $ 16,077.8 million by 2031, growing by 10.7% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-51498","format-standard","category-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Transcriptomics Market Report to 2031 - Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Transcriptomics Market Report to 2031 - Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Transcriptomics Market 2021-2031 by Component, Technology, Application, End User, and Region: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global transcriptomics market will reach $ 16,077.8 million by 2031, growing by 10.7% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-02T11:02:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221202005153\/en\/1653552\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Transcriptomics Market Report to 2031 &#8211; Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-12-02T11:02:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/\"},\"wordCount\":626,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221202005153\\\/en\\\/1653552\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Transcriptomics Market Report to 2031 - Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221202005153\\\/en\\\/1653552\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-12-02T11:02:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221202005153\\\/en\\\/1653552\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221202005153\\\/en\\\/1653552\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Transcriptomics Market Report to 2031 &#8211; Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Transcriptomics Market Report to 2031 - Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Transcriptomics Market Report to 2031 - Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Transcriptomics Market 2021-2031 by Component, Technology, Application, End User, and Region: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global transcriptomics market will reach $ 16,077.8 million by 2031, growing by 10.7% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-02T11:02:34+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221202005153\/en\/1653552\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Transcriptomics Market Report to 2031 &#8211; Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-12-02T11:02:34+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/"},"wordCount":626,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221202005153\/en\/1653552\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/","name":"Global Transcriptomics Market Report to 2031 - Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221202005153\/en\/1653552\/21\/logo.jpg","datePublished":"2022-12-02T11:02:34+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221202005153\/en\/1653552\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221202005153\/en\/1653552\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-transcriptomics-market-report-to-2031-featuring-10x-genomics-agilent-technologies-bio-techne-and-cytiva-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Transcriptomics Market Report to 2031 &#8211; Featuring 10x Genomics, Agilent Technologies, Bio-Techne and Cytiva Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51498"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51498\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}